Work

Long-term efficacy but rare sustained remission: individual-level 5-year stability in anti-IL5/Rα biologic therapy response for severe asthma

Year: 2025

Type: article

Study design: Observational Study

Source: European Respiratory Journal

DOI: 10.1183/13993003.00926-2025

Authors: Kjell Erik Julius Håkansson, Susanne Hansen, Marianne Baastrup Soendergaard, Anna von Bülow, Ole Hilberg, Barbara Bonnesen, Claus Rikard Johnsen, Sofie Lock-Johansson, Lycely Dongo, Maria Bisgaard Borup, Roxana Vijdea, Linda Makowska Rasmussen, Johannes Martin Schmid, Charlotte Suppli Ulrik, Celeste Porsbjerg, Anne Sofie Bjerrum

Institutions: Bispebjerg Hospital, Copenhagen University Hospital, Vejle Sygehus, Lillebaelt Hospital, Gentofte Hospital, Odense University Hospital, Zealand University Hospital, Aalborg University Hospital, Aarhus University Hospital, Hvidovre Hospital

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Novartis, Teva Pharmaceutical Industries

OpenAlex ID: W4416757133

FWCI: 2.187

Cites:

Cited by: 4

Related to: